Cargando…

Chirality matters: stereo-defined phosphorothioate linkages at the termini of small interfering RNAs improve pharmacology in vivo

A critical challenge for the successful development of RNA interference-based therapeutics therapeutics has been the enhancement of their in vivo metabolic stability. In therapeutically relevant, fully chemically modified small interfering RNAs (siRNAs), modification of the two terminal phosphodiest...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jahns, Hartmut, Taneja, Nate, Willoughby, Jennifer L S, Akabane-Nakata, Masaaki, Brown, Christopher R, Nguyen, Tuyen, Bisbe, Anna, Matsuda, Shigeo, Hettinger, Matt, Manoharan, Rajar M, Rajeev, Kallanthottathil G, Maier, Martin A, Zlatev, Ivan, Charisse, Klaus, Egli, Martin, Manoharan, Muthiah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Chemical Biology and Nucleic Acid Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860597/ https://www.ncbi.nlm.nih.gov/pubmed/34268578 http://dx.doi.org/10.1093/nar/gkab544

Ejemplares similares

Structural basis for the synergy of 4′- and 2′-modifications on siRNA nuclease resistance, thermal stability and RNAi activity
por: Harp, Joel M, et al.
Publicado: (2018)

Small circular interfering RNAs (sciRNAs) as a potent therapeutic platform for gene-silencing
por: Jahns, Hartmut, et al.
Publicado: (2021)

Stabilizing contributions of sulfur-modified nucleotides: crystal structure of a DNA duplex with 2′-O-[2-(methoxy)ethyl]-2-thiothymidines
por: Diop-Frimpong, Benjamin, et al.
Publicado: (2005)

Mechanisms of single-stranded phosphorothioate modified antisense oligonucleotide accumulation in hepatocytes
por: Koller, Erich, et al.
Publicado: (2011)

A Chemical Approach to Introduce 2,6-Diaminopurine and 2-Aminoadenine Conjugates into Oligonucleotides without Need for Protecting Groups
por: Madaoui, Mimouna, et al.
Publicado: (2022)

Chemistry, structure and function of approved oligonucleotide therapeutics
por: Egli, Martin, et al.
Publicado: (2023)

Role of a “Magic” Methyl: 2′-Deoxy-2′-α-F-2′-β-C-methyl Pyrimidine Nucleotides Modulate RNA Interference Activity through Synergy with 5′-Phosphate Mimics and Mitigation of Off-Target Effects
por: Guenther, Dale C., et al.
Publicado: (2022)

Acyclic (S)-glycol nucleic acid (S-GNA) modification of siRNAs improves the safety of RNAi therapeutics while maintaining potency
por: Egli, Martin, et al.
Publicado: (2023)

Stereo-Controlled Liquid Phase Synthesis of Phosphorothioate Oligonucleotides on a Soluble Support
por: Rosenqvist, Petja, et al.
Publicado: (2023)

Evaluation of GalNAc-siRNA Conjugate Activity in Pre-clinical Animal Models with Reduced Asialoglycoprotein Receptor Expression
por: Willoughby, Jennifer L.S., et al.
Publicado: (2018)

siRNAs containing 2′-fluorinated Northern-methanocarbacyclic (2′-F-NMC) nucleotides: in vitro and in vivo RNAi activity and inability of mitochondrial polymerases to incorporate 2′-F-NMC NTPs
por: Akabane-Nakata, Masaaki, et al.
Publicado: (2021)

Crystal structure, stability and in vitro RNAi activity of oligoribonucleotides containing the ribo-difluorotoluyl nucleotide: insights into substrate requirements by the human RISC Ago2 enzyme
por: Li, Feng, et al.
Publicado: (2007)

Aminooxy Click Chemistry as a Tool for Bis-homo and Bis-hetero Ligand Conjugation to Nucleic Acids
por: Datta, Dhrubajyoti, et al.
Publicado: (2022)

Pharmacodynamic and Pharmacokinetic Properties of Full Phosphorothioate Small Interfering RNAs for Gene Silencing In Vivo
por: Berk, Christian, et al.
Publicado: (2021)

Synthesis, chirality-dependent conformational and biological properties of siRNAs containing 5′-(R)- and 5′-(S)-C-methyl-guanosine
por: Mikami, Atsushi, et al.
Publicado: (2020)

Specificity, duplex degradation and subcellular localization of antagomirs
por: Krützfeldt, Jan, et al.
Publicado: (2007)

Stereochemical bias introduced during RNA synthesis modulates the activity of phosphorothioate siRNAs
por: Jahns, Hartmut, et al.
Publicado: (2015)

Modulation of thermal stability can enhance the potency of siRNA
por: Addepalli, Haripriya, et al.
Publicado: (2010)

Selection of GalNAc-conjugated siRNAs with limited off-target-driven rat hepatotoxicity
por: Janas, Maja M., et al.
Publicado: (2018)

Unexpected origins of the enhanced pairing affinity of 2′-fluoro-modified RNA
por: Pallan, Pradeep S., et al.
Publicado: (2011)

Overcoming GNA/RNA base-pairing limitations using isonucleotides improves the pharmacodynamic activity of ESC+ GalNAc-siRNAs
por: Schlegel, Mark K, et al.
Publicado: (2021)

A Glu-urea-Lys Ligand-conjugated Lipid Nanoparticle/siRNA System Inhibits Androgen Receptor Expression In Vivo
por: Lee, Justin B, et al.
Publicado: (2016)

Effect of chemical modifications on modulation of gene expression by duplex antigene RNAs that are complementary to non-coding transcripts at gene promoters
por: Watts, Jonathan K., et al.
Publicado: (2010)

Crystal structure of Middle East respiratory syndrome coronavirus helicase
por: Hao, Wei, et al.
Publicado: (2017)

AMPA receptor trafficking and LTP: Carboxy-termini, amino-termini and TARPs
por: Díaz-Alonso, Javier, et al.
Publicado: (2021)

RNA duplexes with abasic substitutions are potent and allele-selective inhibitors of huntingtin and ataxin-3 expression
por: Liu, Jing, et al.
Publicado: (2013)

Chimeric siRNAs with chemically modified pentofuranose and hexopyranose nucleotides: altritol-nucleotide (ANA) containing GalNAc–siRNA conjugates: in vitro and in vivo RNAi activity and resistance to 5′-exonuclease
por: Kumar, Pawan, et al.
Publicado: (2020)

Phosphorothioate DNA as an antioxidant in bacteria
por: Xie, Xinqiang, et al.
Publicado: (2012)

siRNA carrying an (E)-vinylphosphonate moiety at the 5΄ end of the guide strand augments gene silencing by enhanced binding to human Argonaute-2
por: Elkayam, Elad, et al.
Publicado: (2017)

siRNA carrying an (E)-vinylphosphonate moiety at the 5΄ end of the guide strand augments gene silencing by enhanced binding to human Argonaute-2
por: Elkayam, Elad, et al.
Publicado: (2017)

Investigation of factors influencing the separation of diastereomers of phosphorothioated oligonucleotides
por: Enmark, Martin, et al.
Publicado: (2019)

Impact of enhanced metabolic stability on pharmacokinetics and pharmacodynamics of GalNAc–siRNA conjugates
por: Nair, Jayaprakash K., et al.
Publicado: (2017)

The RNA-binding protein vigilin regulates VLDL secretion through modulation of Apob mRNA translation
por: Mobin, Mehrpouya B., et al.
Publicado: (2016)

Synthesis of phosphorothioates using thiophosphate salts
por: Kaboudin, Babak, et al.
Publicado: (2006)

Development of Phosphorothioate DNA and DNA Thioaptamers
por: Volk, David E., et al.
Publicado: (2017)

Electronic Structures of LNA Phosphorothioate Oligonucleotides
por: Bohr, Henrik G., et al.
Publicado: (2017)

Phosphorothioate modified oligonucleotide–protein interactions
por: Crooke, Stanley T, et al.
Publicado: (2020)

Gold-catalyzed alkenylation and arylation of phosphorothioates
por: Urvashi, et al.
Publicado: (2023)

Advanced siRNA Designs Further Improve In Vivo Performance of GalNAc-siRNA Conjugates
por: Foster, Donald J., et al.
Publicado: (2018)

Systematic Assessment of Protein C-Termini Mutated in Human Disorders
por: FitzHugh, Zachary T., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hq387n0pg1ql43ogu1b6kbh17c